Clinical trial
Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients
NCT03713645 is registered in ClinicalTrials.gov with Temple University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients
- Lead sponsor
- Temple University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 12, 2018
- Completion date
- January 31, 2022
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
kidney transplant